Latar belakang: Nuclear factor kappa B (NF-κB) berperan dalam proses onkogenesis. Aktifitas NF-κB pada kultur sel trofoblas mola hidatidosa komplit (MHK) 
receptor signal transduction pathway that leads to increase in proliferation and inhibition of apoptosis of endometrial stromal cells. 3 Nuclear factor kappa B (NF-κB) is known to have a function in the regulation of immune and inflammatory responses, but recently growing scientific evidence also supports its role in oncogenesis. On tumor cells, a variety of molecular changes can cause the activation of NF-κB. This activation leads to deregulation of gene expression under the control of NF-κB. Changes
The process of carcinogenesis from hydatidiform mole into gestational trophoblastic tumor is still unclear and the limited available information can not clearly define the process. Several factors are known to play a role in the process of carcinogenesis including DNA ploidy, phospholipid expression, oncogenes, tumor suppressor genes, nutrition and hormonal status. 1, 2 Normal and pathological trophoblast cells are histologically similar, and both express estrogen receptor. Several theories have been proposed to explain the development of malignancy. One of the contributing factors is estrogen in certain gene expression may participate in cancer growth and progression. Therefore, there might be a relationship between NF-κB and carcinogenesis. 4 NF-κB is a transcription factor that is known to play an important role in controlling immune and inflammatory responses. There are presently five members of the mammalian NF-κB/Rel family: NF-κB/p50, NF-κB/p52, c-Rel, RelA/p65 and RelB. The p50 and 65 subunits, is normally retained in the cytoplasm through interactions with inhibitor proteins IκBα and IκBβ. Inductive stimuli (TNFα, IL-1, bacterial endotoxin, etc.) lead to the phosphorylation and degradation of IκB, allowing NF-κB to enter the nucleus and regulate gene expression. 5, 6 Recently, estrogen receptor (ER) was found to act together with NF-κB in a positive manner to synergistically enhance certain gene transcription. There is a positive cross-talk between ER and NF-κB to promote the survival of cancer cells and progress to a more aggressive phenotype. 7 However, another finding showed that 17β-estradiol (E2) could inhibit NF-κB activity and therefore enhanced the process of apoptosis. It was reported that in tamoxifenresistant MCF-7 tumors, E2 caused down regulation of p65, a subunit of NF-κB, which was correlated with anti-proliferative and pro-apoptotic events. From these studies, it can be assumed that E2 might induce apoptosis and cause regression of tamoxifenresistant MCF-7 tumors, and in addition, act through suppression of NF-κB as a factor of pro-survival/ anti-apoptotic. 8 In another research, a novel positive interaction was shown between the ER and NF-κB dependent signalling pathways in an endometrial epithelial cell line derived from healthy endometrium. NF-κB activation modulates ER activity by an ER and NF-κB dependent mechanism and can enhance ERmediated endogenous gene expression in an in vitro human endometrial epithelial cell model. 9 In women, physiological levels of E2 during normal menstrual cycle is 10 pg/mL and may increase to 35,000 pg/ mL during pregnancy. 10 This study was conducted in order to get scientific information on the effect of E2 on the expression of NF-κB in cultured CHM trophoblast cells. In this study we used different doses of E2, to determine at which dose it increased the expression of NF-κB in the culture of complete hydatidiform mole (CHM) trophoblast cells. The starting dose was 10 pg/mL, which is the normal level during menstruation. 
METHODS

This was an experimental study conducted between
Isolation and culture of CHM trophoblast cells
The bubbles of mole were washed by NaCl until free from erythrocytes, and were further washed 2 times with Dulbecco's phosphate buffered saline (DPBS) added with a final concentration of 100 U/mL penicillin and 100 μg/mL streptomycin. After the addition of antibiotics, this solution [DPBS] should be kept at 2-8°C and used within one week. Finally, the bubbles were washed with serum free media.
To isolate the cells, the bubbles were incubated in a solution of Collagenase (type 1) 7 mg/10 cc for 2 hours, and centrifuged 2,000 rpm for 7 minutes. The supernatant was removed, and the pellet was resuspended in serum free media. The centrifugation was repeated and the resulting pellet was resuspended in 4 mL culture medium, which contain newborn calf serum (NCS, [Sigma N4637]) and 10% FBS, then incubated in 5% CO 2 incubator, in 37°C. Further, the culture was observed daily under a microscope to detect cell growth. Identification of trophoblast cells were done by hCG β examination.
NF-κB expression study
We divided the CHM trophoblast cultures into 6 groups i.e. those which were treated with various doses of E2 (beta estradiol powder [Sigma]) i.e. 10, 100, 300, 600, 1000 pg/mL and a control group (without E2).
NF-κB immunohistochemistry (IHC) staining were performed in the Biochemistry Laboratory, Faculty of Medicine, Brawijaya University. Then, 400x enlarged micro-photographs were taken. The IHC photographs were analysed by counting and measuring red-green-blue brightness value (RGBbv) hystogram of 200 cell nuclei using adobe photoshop CS2 to collect mean data of color thickness. Cell with abundant expression of NF-κB, showed thickened color in the nuclei. The thicker the color was, the smaller was the value in the adobe photoshop CS2 hystogram.
Data analysis
ANOVA test was performed to compare NF-κB expression in CHM trophoblast cells that were treated with variable doses of E2 and control.
RESULTS
Expression of NF-κB in CHM trophoblast cells without E2 treatment (control) can be seen in figure 1 . Expression of NF-κB in CHM trophoblast cells with 1000 pg/mL of E2 treatment can be seen in figure 2 . Expression of NF-κB in CHM trophoblast cells with various doses E2 treatment can be seen in table 1. Table 1 shows mean data with standard deviation of cell color thickness, which expressed NF-κB in RGBbv.
The table shows that treatment of E2 have different influence on NF-κB expression in CHM's cells compared with control. Cell with abundant expression of NF-κB, showed thickened color in the nuclei. The thicker the color was, the smaller was the value in the adobe photoshop CS2 hystogram. ANOVA test showed significant differences (p < 0.007) in the expression of NF-κB in CHM trophoblast cells with various doses of E2 treatment and control.
DISCUSSION
Estrogen is a steroid hormone family that is synthesized in the ovarian and extra ovarian tissues. Med J Indones 17β-estradiol is the primary estrogen from the ovaries. Natural estrogens are steroids hormones, while some synthetic ones are non-steroidal. Natural estrogen consists of 17β-estradiol (E2), estrone (E1) and estriol (E3). 17β-estradiol is the most potent type of estrogen, followed by E1 and E3. Estrogen receptor is an important factor in the mechanism of action of estrogen and can be found in some tissues, such as central nervous system, cardiovascular system, immune system, urogenital tract, gastrointestinal tract, kidney, lung, mammary gland, uterus and bone. Both estrogen receptors (α and β) play a different role on tissues. ER α plays an important role in mammary gland and uterus, whereas in other tissues ER β is more important. Signaling pathways mediated by ER is thought to cause the growth of normal tissues, preneoplasm and neoplasms. There are 3 lines of estrogen transduction signaling in carcinogenesis, including genomic, non-genomic and mitochondrial pathways. Estrogen influence on NF-κB activity is most likely through mitochondrial pathways. 11 In this case, the bound estrogen receptor in the plasma membrane and/or mitochondrial respiratory complexes will form ROS that results in kinase activation and activation of the IKKβ subunit that is responsible for the phosphorylation of serine residue in IκB. After phosphorylation, IκB protein ubiquitin-dependent degradation by the proteasome happens, and NF-κB is translocated to the nucleus, so that NF-κB becomes separated from the cytoplasm, and becomes active as a transcription factor, causes proliferation, antiapoptosis, and eventually causing a cell to become malignant. 12 Those findings corroborate the results of this study, which showed significant differences (p < 0.007) between the expressions of NF-κB in CHM trophoblast cell cultures, which were given E2 with varying doses compared to control.
Our results are in line with a study on breast cancer cells with and without the anti-estrogen tamoxifen to test the extent of cross-talk between ER and NF-κB, where a microarray study was done on MCF-7 breast cancer cells that were administered with E2, and tumor necrosis factor alpha (TNFα). The study found positive crosstalks with three patterns, namely: (a) TNFα increased the activity of about 30% of E2 regulated genes, (b) E2 increased the activity of about 15% of the TNFα regulated genes (c) E2 + TNFα causes additional upregulation of about 60 genes. Moreover, these results showed the prosurvival role of ER, and NF-κB that was involved in protecting breast cancer cells to apoptosis. On the whole, there is positive crosstalk between ER and NF-κB, which act together to promote the survival of cancer cells and to progress to a more aggressive phenotype. 7 Further researches are needed to determine whether the positive cross talk between E2 and NF-κB in cultured CHM trophoblast cells occurs through receptor or nonreceptor pathway by giving tamoxifen as estrogen receptor competitors. In addition, oral contraception can be provided to women after curretage of mola hydatidiform, because in preparations there are progesterone as anti estrogen.
The limitations of this study is that the measurement of the expression of NF-κB was done on microphotograph from ordinary microscope using Adobe Photoshop CS2, which was not able to assess whether the expression of NF-κB is located entirely in the nucleus or in the cytoplasm, as assessment using confocal microscopy that can obtain more accurate results.
In conclusion, there were significant differences in the expression of NF-κB in CHM trophoblast cell culture. Treatment of CHM trophoblast cell culture with escalating doses of E2 was associated with increased expression of NF-κB in a dose-dependent manner.
